Lower LRP2 was associated with dedifferentiated subtypes and poorer survival in clear-cell/papillary renal cell carcinoma, papillary thyroid carcinoma, mesothelioma, and invasive breast carcinoma, with methylation-linked repression as a plausible mechanism [8]. Here, LRP2 is linked to papillary renal cell carcinoma.